AI Article Synopsis
- Patients with transfusion-dependent myelodysplastic syndromes (MDS) face a higher risk of heart problems due to ongoing anemia and excess iron in the body.
- The text discusses a specific case where a patient with MDS experienced heart failure caused by iron overload.
- After undergoing intensive iron chelation therapy, the patient's cardiac function improved significantly.
Article Abstract
Patients with transfusion-dependent myelodysplastic syndromes (MDS) have an increased risk of cardiac events, due to both chronic anemia and iron overload. Here, we report the recovery of cardiac function after an intensive iron chelation therapy in a MDS patient who had developed heart failure due to iron overload.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641482 | PMC |
| http://dx.doi.org/10.1002/ccr3.407 | DOI Listing |
Publication Analysis
Top Keywords
heart failure
8
transfusion-dependent myelodysplastic
8
chelation therapy
8
iron overload
8
iron
4
iron overload-related
4
overload-related heart
4
failure patient
4
patient transfusion-dependent
4
myelodysplastic syndrome
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!